España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Capitol Series Trust The Nightview Fund NITE
NITE
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$30.38
-0.02
-0.05%
At close: -
$27.87
-2.51
-8.28%
After Hours: Nov 29, 2:50 PM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Capitol Series Trust The Nightview Fund NITE (ARCA:NITE)
Capitol Series Trust The Nightview Fund NITE (ARCA: NITE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 03, 2024
BlackRock Makes $12 Billion Power Move - Agrees To Acquire HPS To Bolster Private Credit Offerings
Lekha Gupta
Tuesday, November 05, 2024
Wynn Resorts' Q3 Performance Misses Expectations Amid Strategic Investments
Lekha Gupta
Wednesday, October 16, 2024
BlackRock In Talks To Deepen Ties With Mukesh Ambani For Private Credit Venture
Nabaparna Bhattacharya
Friday, October 11, 2024
BlackRock's Steady Climb: Q3 Earnings Beat Projections, Assets Under Management Soars To $11.5T
Lekha Gupta
Friday, September 27, 2024
Wynn Resorts' New York Casino Bid Could Act As A Positive Catalyst: Analyst
Lekha Gupta
Monday, September 09, 2024
Elon Musk To Be Summoned By UK Parliament Over Role of Social Media Platform X
Michael Juliano
Thursday, September 05, 2024
Trump Plans To Appoint Elon Musk To Government Efficiency Commission If Elected, Tesla CEO Says He'll Do It For Free
Michael Juliano
Wednesday, August 21, 2024
Hyatt Expands Its Empire: Inks Deal To Bring Standard Hotels Under Its Wing
Lekha Gupta
Wednesday, July 17, 2024
BlackRock Sells $2.5B In Bonds To Help Fund Preqin Deal: Report
Michael Juliano
Monday, July 01, 2024
BlackRock's Aladdin Gets Smarter: $3.2B Deal Adds Preqin's Private Markets Data
Lekha Gupta
Wednesday, June 05, 2019
Nightstar Therapeutics Receives Court In Conn...
Benzinga Newsdesk
Wednesday, May 29, 2019
Nightstar Therapeutics Offers Expected Timeta...
Benzinga Newsdesk
Wednesday, May 08, 2019
Nightstar Therapeutics Reports Shareholders A...
Benzinga Newsdesk
Wednesday, March 27, 2019
6 Gene Therapy M&A Targets On The Radar
Shanthi Rexaline
Monday, March 25, 2019
7 Biggest Price Target Changes For Monday
Lisa Levin
Barclays Downgrades Nightstar Therapeutics to Equal-Weight, Lowers Price Target to $26
Vick Meyer
Sunday, March 10, 2019
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs
Shanthi Rexaline
Tuesday, March 05, 2019
Analysts Laud Biogen's M&A Strategy Following Deal to Buy Gene Therapy Company Nightstar
Shanthi Rexaline
10 Biggest Price Target Changes For Tuesday
Lisa Levin
Benzinga's Top Upgrades, Downgrades For March 5, 2019
Lisa Levin
Benzinga Pro's Top 10 Most-Searched Tickers F...
Benzinga Newsdesk
SVB Leerink Downgrades Nightstar Therapeutics to Market Perform, Lowers Price Target to $25.50
Vick Meyer
Mizuho Downgrades Nightstar Therapeutics to Neutral, Raises Price Target to $25.50
Vick Meyer
A Peek Into The Markets: US Stock Futures Up; Target Beats Q4 Estimates
Lisa Levin
UBS Downgrades Nightstar Therapeutics to Neutral, Raises Price Target to $25.50
Vick Meyer
BMO Capital Downgrades Nightstar Therapeutics to Market Perform, Lowers Price Target to $25.50
Vick Meyer
62 Biggest Movers From Yesterday
Lisa Levin
Monday, March 04, 2019
Mid-Afternoon Market Update: Nightstar Therapeutics Surges On Acquisition News; Evoke Pharma Shares Plunge
Lisa Levin
50 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Mid-Day Market Update: U.S. Stocks Turn Negative; Dow Down Over 350 Points
Lisa Levin
Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations
Lisa Levin
10 Biggest Price Target Changes For Monday
Lisa Levin
Biogen Bets On Gene Therapy, Agrees To Acquire Nightstar For $800M
Shanthi Rexaline
Benzinga's Top Upgrades, Downgrades For March 4, 2019
Lisa Levin
30 Stocks Moving In Monday's Pre-Market Session
Lisa Levin
Nightstar Therapeutics shares are trading hig...
Benzinga Newsdesk
Cantor Fitzgerald Downgrades Nightstar Therapeutics to Neutral, Lowers Price Target to $25.50
Vick Meyer
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
Lisa Levin
Nightstar Therapeutics Announces Agreement to be Acquired by Biogen for $25.50/Share in Cash
Charles Gross
Tuesday, February 26, 2019
72 Biggest Movers From Yesterday
Lisa Levin
Tuesday, January 15, 2019
56 Biggest Movers From Yesterday
Lisa Levin
Monday, December 17, 2018
Benzinga's Top Upgrades, Downgrades For December 17, 2018
Lisa Levin
Barclays Initiates Coverage On Nightstar Ther...
Benzinga Newsdesk
Tuesday, November 13, 2018
Nightstar Therapeutics Q3 EPS $(0.27) vs. $(0...
Charles Gross
Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP
Charles Gross
Tuesday, October 30, 2018
Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk
The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio
Shanthi Rexaline
Thursday, October 11, 2018
Benzinga's Top Upgrades, Downgrades For October 11, 2018
Lisa Levin
26 Stocks Moving In Thursday's Pre-Market Session
Lisa Levin
Cantor Fitzgerald Initiates Coverage On Night...
Benzinga Newsdesk
Show More